Report Summary
Eternity Insights has published a new study on Global Aquaculture Therapeutics Market focusing on key segments as by Type (Formalin Solution, Chorionic Gonadotropin, Florfenicol, Tricaine Methane Sulfonate, Oxytetracycline, Hydrogen Peroxide), by Application (Veterinary Pharmacies, Veterinary Hospitals, E-Commerce, Veterinary Clinics), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Aquaculture Therapeutics Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Aquaculture Therapeutics Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Aquaculture Therapeutics Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Aquaculture Therapeutics Market Segmentation:
Aquaculture Therapeutics Market, By Type
- Formalin Solution
- Chorionic Gonadotropin
- Florfenicol
- Tricaine Methane Sulfonate
- Oxytetracycline
- Hydrogen Peroxide
Aquaculture Therapeutics Market, By Application
- Veterinary Pharmacies
- Veterinary Hospitals
- E-Commerce
- Veterinary Clinics
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Aquaculture Therapeutics market in terms of demand generation. The Aquaculture Therapeutics market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Aquaculture Therapeutics market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Aquaculture Therapeutics Market Taxonomy:
To learn more about this report
Global Aquaculture Therapeutics Market Competitive Landscape
The global Aquaculture Therapeutics market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- TunaTech GmbH
- ViAqua Therapeutics Ltd.
- Alpharma Inc.
- Blue Ridge Aquaculture
- Cermaq ASA
- Cooke Aquaculture
- Nireus Aquaculture S.A.
- Tassal group Ltd.
- Nireus S.A.
- Unima Group
- Nutreco Holding N.V.
- Kona Bay Marine Resources
- Royal Greenland
- Sea Watch International Ltd.
- Selonda Aquaculture S.A.
- StarKist Taylor Shellfish Inc.
- TriMarine International
- Seafood Company
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Formalin Solution, Chorionic Gonadotropin, Florfenicol, Tricaine Methane Sulfonate, Oxytetracycline, Hydrogen Peroxide |
| By Application Outlook |
Veterinary Pharmacies, Veterinary Hospitals, E-Commerce, Veterinary Clinics |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
TunaTech GmbH, ViAqua Therapeutics Ltd., Alpharma Inc., Blue Ridge Aquaculture, Cermaq ASA, Cooke Aquaculture, Nireus Aquaculture S.A., Tassal group Ltd., Nireus S.A., Unima Group, Nutreco Holding N.V., Kona Bay Marine Resources, Royal Greenland, Sea Watch International Ltd., Selonda Aquaculture S.A., StarKist Taylor Shellfish Inc., TriMarine International, Seafood Company |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
Global Aquaculture Therapeutics Market Research Report 2021-2027, by Manufacturers, Regions, Types and Applications
1 Study Coverage
1.1 Aquaculture Therapeutics Product
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Aquaculture Therapeutics Market Size Growth Rate by Type
1.4.2 Formalin Solution
1.4.3 Chorionic Gonadotropin
1.4.4 Florfenicol
1.4.5 Tricaine Methane Sulfonate
1.4.6 Oxytetracycline
1.4.7 Hydrogen Peroxide
1.5 Market by Application
1.5.1 Global Aquaculture Therapeutics Market Size Growth Rate by Application
1.5.2 Veterinary Pharmacies
1.5.3 Veterinary Hospitals
1.5.4 E-Commerce
1.5.5 Veterinary Clinics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Aquaculture Therapeutics Production
2.1.1 Global Aquaculture Therapeutics Revenue 2017-2027
2.1.2 Global Aquaculture Therapeutics Production 2017-2027
2.1.3 Global Aquaculture Therapeutics Capacity 2017-2027
2.1.4 Global Aquaculture Therapeutics Marketing Pricing and Trends
2.2 Aquaculture Therapeutics Growth Rate (CAGR) 2021-2027
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Key Aquaculture Therapeutics Manufacturers
2.4 Market Drivers, Trends and Issues
2.5 Macroscopic Indicator
2.5.1 GDP for Major Regions
2.5.2 Price of Raw Materials in Dollars: Evolution
3 Market Size by Manufacturers
3.1 Aquaculture Therapeutics Production by Manufacturers
3.1.1 Aquaculture Therapeutics Production by Manufacturers
3.1.2 Aquaculture Therapeutics Production Market Share by Manufacturers
3.2 Aquaculture Therapeutics Revenue by Manufacturers
3.2.1 Aquaculture Therapeutics Revenue by Manufacturers (2017-2020)
3.2.2 Aquaculture Therapeutics Revenue Share by Manufacturers (2017-2020)
3.3 Aquaculture Therapeutics Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 Aquaculture Therapeutics Production by Regions
4.1 Global Aquaculture Therapeutics Production by Regions
4.1.1 Global Aquaculture Therapeutics Production Market Share by Regions
4.1.2 Global Aquaculture Therapeutics Revenue Market Share by Regions
4.2 United States
4.2.1 United States Aquaculture Therapeutics Production
4.2.2 United States Aquaculture Therapeutics Revenue
4.2.3 Key Players in United States
4.2.4 United States Aquaculture Therapeutics Import & Export
4.3 Europe
4.3.1 Europe Aquaculture Therapeutics Production
4.3.2 Europe Aquaculture Therapeutics Revenue
4.3.3 Key Players in Europe
4.3.4 Europe Aquaculture Therapeutics Import & Export
4.4 China
4.4.1 China Aquaculture Therapeutics Production
4.4.2 China Aquaculture Therapeutics Revenue
4.4.3 Key Players in China
4.4.4 China Aquaculture Therapeutics Import & Export
4.5 Japan
4.5.1 Japan Aquaculture Therapeutics Production
4.5.2 Japan Aquaculture Therapeutics Revenue
4.5.3 Key Players in Japan
4.5.4 Japan Aquaculture Therapeutics Import & Export
4.6 Other Regions
4.6.1 South Korea
4.6.2 India
4.6.3 Southeast Asia
5 Aquaculture Therapeutics Consumption by Regions
5.1 Global Aquaculture Therapeutics Consumption by Regions
5.1.1 Global Aquaculture Therapeutics Consumption by Regions
5.1.2 Global Aquaculture Therapeutics Consumption Market Share by Regions
5.2 North America
5.2.1 North America Aquaculture Therapeutics Consumption by Application
5.2.2 North America Aquaculture Therapeutics Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe Aquaculture Therapeutics Consumption by Application
5.3.2 Europe Aquaculture Therapeutics Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Aquaculture Therapeutics Consumption by Application
5.4.2 Asia Pacific Aquaculture Therapeutics Consumption by Countries
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Indonesia
5.4.9 Thailand
5.4.10 Malaysia
5.4.11 Philippines
5.4.12 Vietnam
5.5 Central & South America
5.5.1 Central & South America Aquaculture Therapeutics Consumption by Application
5.5.2 Central & South America Aquaculture Therapeutics Consumption by Countries
5.5.3 Brazil
5.6 Middle East and Africa
5.6.1 Middle East and Africa Aquaculture Therapeutics Consumption by Application
5.6.2 Middle East and Africa Aquaculture Therapeutics Consumption by Countries
5.6.3 Turkey
5.6.4 GCC Countries
5.6.5 Egypt
5.6.6 South Africa
6 Market Size by Type
6.1 Global Aquaculture Therapeutics Breakdown Dada by Type
6.2 Global Aquaculture Therapeutics Revenue by Type
6.3 Aquaculture Therapeutics Price by Type
7 Market Size by Application
7.1 Overview
7.2 Global Aquaculture Therapeutics Breakdown Dada by Application
7.2.1 Global Aquaculture Therapeutics Consumption by Application
7.2.2 Global Aquaculture Therapeutics Consumption Market Share by Application (2017-2020)
8 Manufacturers Profiles
8.1 TunaTech GmbH
8.1.1 TunaTech GmbH Company Details
8.1.2 Company Description
8.1.3 Capacity, Production and Value of Aquaculture Therapeutics
8.1.4 Aquaculture Therapeutics Product Description
8.1.5 SWOT Analysis
8.2 ViAqua Therapeutics Ltd.
8.2.1 ViAqua Therapeutics Ltd. Company Details
8.2.2 Company Description
8.2.3 Capacity, Production and Value of Aquaculture Therapeutics
8.2.4 Aquaculture Therapeutics Product Description
8.2.5 SWOT Analysis
8.3 Alpharma Inc.
8.3.1 Alpharma Inc. Company Details
8.3.2 Company Description
8.3.3 Capacity, Production and Value of Aquaculture Therapeutics
8.3.4 Aquaculture Therapeutics Product Description
8.3.5 SWOT Analysis
8.4 Blue Ridge Aquaculture
8.4.1 Blue Ridge Aquaculture Company Details
8.4.2 Company Description
8.4.3 Capacity, Production and Value of Aquaculture Therapeutics
8.4.4 Aquaculture Therapeutics Product Description
8.4.5 SWOT Analysis
8.5 Cermaq ASA
8.5.1 Cermaq ASA Company Details
8.5.2 Company Description
8.5.3 Capacity, Production and Value of Aquaculture Therapeutics
8.5.4 Aquaculture Therapeutics Product Description
8.5.5 SWOT Analysis
8.6 Cooke Aquaculture
8.6.1 Cooke Aquaculture Company Details
8.6.2 Company Description
8.6.3 Capacity, Production and Value of Aquaculture Therapeutics
8.6.4 Aquaculture Therapeutics Product Description
8.6.5 SWOT Analysis
8.7 Nireus Aquaculture S.A.
8.7.1 Nireus Aquaculture S.A. Company Details
8.7.2 Company Description
8.7.3 Capacity, Production and Value of Aquaculture Therapeutics
8.7.4 Aquaculture Therapeutics Product Description
8.7.5 SWOT Analysis
8.8 Tassal group Ltd.
8.8.1 Tassal group Ltd. Company Details
8.8.2 Company Description
8.8.3 Capacity, Production and Value of Aquaculture Therapeutics
8.8.4 Aquaculture Therapeutics Product Description
8.8.5 SWOT Analysis
8.9 Nireus S.A.
8.9.1 Nireus S.A. Company Details
8.9.2 Company Description
8.9.3 Capacity, Production and Value of Aquaculture Therapeutics
8.9.4 Aquaculture Therapeutics Product Description
8.9.5 SWOT Analysis
8.10 Unima Group
8.10.1 Unima Group Company Details
8.10.2 Company Description
8.10.3 Capacity, Production and Value of Aquaculture Therapeutics
8.10.4 Aquaculture Therapeutics Product Description
8.10.5 SWOT Analysis
8.11 Nutreco Holding N.V.
8.12 Kona Bay Marine Resources
8.13 Royal Greenland
8.14 Sea Watch International Ltd.
8.15 Selonda Aquaculture S.A.
8.16 StarKist Taylor Shellfish Inc.
8.17 TriMarine International
8.18 Seafood Company
9 Production Forecasts
9.1 Aquaculture Therapeutics Production and Revenue Forecast
9.1.1 Global Aquaculture Therapeutics Production Forecast 2021-2027
9.1.2 Global Aquaculture Therapeutics Revenue Forecast 2021-2027
9.2 Aquaculture Therapeutics Production and Revenue Forecast by Regions
9.2.1 Global Aquaculture Therapeutics Revenue Forecast by Regions
9.2.2 Global Aquaculture Therapeutics Production Forecast by Regions
9.3 Aquaculture Therapeutics Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Aquaculture Therapeutics Production Forecast by Type
9.4.2 Global Aquaculture Therapeutics Revenue Forecast by Type
10 Consumption Forecast
10.1 Consumption Forecast by Application
10.2 Aquaculture Therapeutics Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Aquaculture Therapeutics Consumption Forecast by Countries 2021-2027
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Aquaculture Therapeutics Consumption Forecast by Countries 2021-2027
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Aquaculture Therapeutics Consumption Forecast by Countries 2021-2027
10.5.2 China
10.5.3 Japan
10.5.4 Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Aquaculture Therapeutics Consumption Forecast by Country 2021-2027
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Aquaculture Therapeutics Consumption Forecast by Countries 2021-2027
10.7.2 Middle East and Africa
10.7.3 Turkey
10.7.4 GCC Countries
10.7.5 Egypt
10.7.6 South Africa
11 Upstream, Industry Chain and Downstream Customers Analysis
11.1 Analysis of Aquaculture Therapeutics Upstream Market
11.1.1 Aquaculture Therapeutics Key Raw Material
11.1.2 Typical Suppliers of Key Aquaculture Therapeutics Raw Material
11.1.3 Aquaculture Therapeutics Raw Material Market Concentration Rate
11.2 Aquaculture Therapeutics Industry Chain Analysis
11.3 Marketing & Distribution
11.4 Aquaculture Therapeutics Distributors
11.5 Aquaculture Therapeutics Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter's Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
